Tamara Shafer Hodge

Title: Tamara Shafer Hodge: Innovator in Anti-Diabetic Solutions

Introduction

Tamara Shafer Hodge is a notable inventor based in Ballwin, MO (US). She has made significant contributions to the field of diabetes treatment through her innovative research and development. Her work focuses on the application of FGF21 molecules in combating diabetes-related conditions.

Latest Patents

Tamara holds a patent for "FGF21 conjugates and anti-diabetic uses thereof." This invention provides a FGF21 molecule covalently attached to the combining site of an antibody via a linker. The linker is covalently attached to the side chain of a linking residue within FGF21. The patent outlines various uses of these compounds, including methods to prevent or treat diabetes and diabetes-related conditions. She has 1 patent to her name.

Career Highlights

Throughout her career, Tamara has worked with prominent companies in the pharmaceutical industry. Notably, she has been associated with Covx Technologies Ireland Limited and Pfizer Corporation. Her experience in these organizations has contributed to her expertise in developing innovative solutions for diabetes management.

Collaborations

Tamara has collaborated with esteemed professionals in her field, including Tapan Kanti Das and Tetsuya Ishino. These collaborations have further enhanced her research and development efforts.

Conclusion

Tamara Shafer Hodge is a pioneering inventor whose work in anti-diabetic solutions has the potential to make a significant impact on public health. Her innovative approach to utilizing FGF21 molecules showcases her dedication to advancing medical science.